This molecule acts through leveraging ER expression, which is typically maintained in ET-resistant breast cancer cells, via over-activating the tumor-protective ER-activated anticipatory unfolded protein response (a-UPR) in breast cancer cells to initiate cell death. The gene discussed is ESR1; the disease is neoplasm.